Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effectiveness of the SX ELLA Esophageal Degradable BD (BD Stent) Stent System

NCT01337206 is registered in ClinicalTrials.gov with Cook Group Incorporated as lead sponsor.

NCT NCT01337206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01337206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effectiveness of the SX ELLA Esophageal Degradable BD (BD Stent) Stent System
Lead sponsor
Cook Group Incorporated
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
January 31, 2015
Enrollment
66 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

benign esophageal lesions